Developer docs
API playgroundTry for free, no card

Search company profiles

Breakthru Psychiatric Solutions

Full company profile

uuid002smo4

Namestring
Breakthru Psychiatric Solutions
Legal namestring
Slick Innovations, LLC
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Breakthru Psychiatric Solutions is a private interventional psychiatry practice founded in 2020 during the COVID pandemic by psychiatrist Dr. Karen Giles, MD and business leader Jim Benjamin, operating under the legal entity Slick Innovations, LLC. The practice operates clinics in Sandy Springs and Alpharetta, Georgia, with a third location in Tucker, GA scheduled to open in July 2026. It serves patients with treatment-resistant mental health conditions — primarily major depressive disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD) — who have not responded adequately to traditional antidepressant medications and psychotherapy. Patient volume is generated through a direct-to-consumer model supplemented by healthcare provider referrals, with no enterprise or institutional customers.

The practice's treatment portfolio centers on interventional psychiatric modalities delivered under physician supervision. Core offerings include Transcranial Magnetic Stimulation (TMS) in multiple protocol variants — a standard 9-week protocol, Accelerated TMS (40 iTBS sessions over two weeks), the proprietary ONE-D TMS (20 sessions in a single day combined with Vyvanse and D-cycloserine), AMPLIFI TMS for OCD (targeting DMPFC and rOFC), and MagVenture adolescent TMS for patients ages 15-21. Additional modalities include Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression), IV Ketamine infusions, Prism for PTSD (an FDA-cleared EEG-based neurofeedback device sourced via a partnership with GrayMatters Health), and Vagus Nerve Stimulation. Breakthru positions itself as the first provider in Georgia to offer ONE-D TMS, and reports clinical outcome figures across modalities, including 93.9% depression improvement with TMS, 95.8% with IV Ketamine, 89.7% with Spravato, and 67% clinically significant symptom improvement with Prism.

Revenue is generated through a dual insurance/self-pay billing model. Traditional TMS, Spravato, and VNS are billed through insurance (Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care) with prior authorization, while IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are self-pay only. The practice is bootstrapped with no disclosed external funding rounds, operates with a 1–10 employee footprint including a five-person physician team, and does not publicly disclose revenue.

Short descriptiontext

Breakthru Psychiatric Solutions is a private interventional psychiatry practice in Georgia providing TMS, Spravato, IV Ketamine, Prism for PTSD, and VNS treatments to patients with treatment-resistant depression, anxiety, PTSD, and OCD.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSandy Springs, United States
HQ citystring
Sandy Springs
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
interventional psychiatry, transcranial magnetic stimulation, treatment-resistant depression, esketamine nasal spray, IV ketamine therapy
Industry1 code
PRIMARYHLAFACAL
Behavioral Health for Children & Adolescents (Youth Services)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Other Ambulatory Health Care Services6219
SIC code3 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Health Services8000
Product category
Interventional Psychiatry Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Treatment Services
TypeSubscription Recurring
Description

Revenue generated from providing interventional psychiatric treatments including TMS, Spravato, IV Ketamine, Prism, and VNS. Services are billed through insurance for covered treatments or collected as self-pay for non-covered treatments. Insurance accepted includes Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care.

breakthrupsych.com
2Insurance Reimbursements
TypeManaged Services
Description

Traditional TMS, Spravato, and VNS Therapy are covered by many insurance plans. These treatments require prior authorization and are billed through the patient's insurance provider.

breakthrupsych.com
3Self-Pay Services
TypeOne Time License
Description

IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are not covered by insurance and are collected as self-pay from patients.

breakthrupsych.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details6 tiers
1Traditional TMS - 9-week protocol covered by insurance
ModelSubscriptionBilling cadenceMulti-year contract
Notes

36 treatments over 9 weeks (5x/week for 6 weeks + 3-week taper). Insurance often covers this protocol with prior authorization requiring 2-4 failed medication trials.

breakthrupsych.com
2Accelerated TMS - 2-week protocol (self-pay)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

40 treatments over 2 weeks (4 treatments/day for 10 days). Not covered by insurance. Self-pay only.

breakthrupsych.com
3ONE-D TMS - One-day treatment (self-pay)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

20 sessions in one or two days. Self-pay only. Not covered by insurance.

breakthrupsych.com
4Spravato - FDA-approved nasal spray (insurance covered)
ModelSubscriptionBilling cadenceMonthly
Notes

Twice-weekly for 4 weeks, then weekly for 4 weeks. Covered by many insurance plans with prior authorization.

breakthrupsych.com
5IV Ketamine - Not covered by insurance (self-pay)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Induction phase: 2-3x/week for 2-3 weeks. Maintenance treatments required. Not FDA-approved for depression so not covered by insurance.

breakthrupsych.com
6Prism for PTSD - Not covered by insurance (self-pay)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

15 sessions over 8 weeks. Not covered by insurance at this time.

breakthrupsych.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Breakthru Psychiatric Solutions provides interventional psychiatric treatments for patients with treatment-resistant mental health conditions (depression, anxiety, PTSD, OCD). The practice administers Transcranial Magnetic Stimulation (TMS) with multiple protocols including ONE-D TMS, Accelerated TMS, AMPLIFI TMS for OCD, and TMS for Adolescents; Spravato (esketamine nasal spray); IV Ketamine infusions; Prism for PTSD neurofeedback; and Vagus Nerve Stimulation (VNS) Therapy. Treatments are delivered under psychiatrist supervision at clinic locations in the Atlanta, Georgia metropolitan area.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 93.9% depression improvement, 87.9% anxiety improvement, 42.4% remission rates with TMS
+4 more records
Product overview1 text field

Breakthru Psychiatric Solutions offers interventional psychiatric treatments for treatment-resistant mental health conditions. The core offerings include three main treatment modalities: Transcranial Magnetic Stimulation (TMS) with multiple protocol variants (Standard TMS, Accelerated TMS, ONE-D TMS, AMPLIFI TMS for OCD, and TMS for Adolescents), Spravato (esketamine nasal spray), and IV Ketamine infusions. Additional treatments include Prism for PTSD (neurofeedback therapy) and Vagus Nerve Stimulation (implanted device). These treatments are offered as alternatives or complements to traditional medication management for patients who have not responded to conventional antidepressant therapies.

Product and service1 record
1Transcranial Magnetic Stimulation (TMS)
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-10-30
Description

GrayMatters Health is the manufacturer of Prism for PTSD, an FDA-cleared neurofeedback treatment. Breakthru offers Prism as one of their treatment options for PTSD patients. The news indicates expansion of Prism access across multiple clinics including Georgia locations. Clinical trial data published in the Journal of Psychiatry Research demonstrated 67% clinically significant symptom improvement rate among patients using the device.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers7 records
TypeBroad incumbent
Description

Digital mental health platform offering medication management and therapy for depression and anxiety. Adjacent mental health space but different delivery model (telehealth) and focuses on pharmaceutical rather than interventional approaches, serving some overlapping patient needs.

TypeDirect peer
Description

Major North American network of TMS treatment centers offering similar outpatient interventional psychiatry services for treatment-resistant depression. Directly comparable specialty clinic model serving similar patient populations with TMS-focused treatment protocols and physician-supervised delivery.

TypeBroad incumbent
Description

Established brain health clinic chain offering SPECT imaging and psychiatric evaluation services. Overlapping patient demographic in treatment-resistant mental health but different clinical approach focused on brain imaging diagnostics rather than interventional procedures.

TypeOthers
Description

Online therapy platform connecting patients with licensed therapists via text, audio, and video messaging. Different delivery model and treatment approach (talk therapy vs. interventional psychiatry), but serves similar mental health patient population through employer benefits and direct-to-consumer channels.

TypeBroad incumbent
Description

Larger psychiatric services platform offering comprehensive mental health care including therapy, medication management, and interventional treatments. Overlapping patient base in treatment-resistant mental health but broader service portfolio and significantly larger operational scale than Breakthru's specialty focus.

TypeOthers
Description

Manufacturer of the NeuroStar TMS system, a widely-used platform in interventional psychiatry clinics including adolescent applications. Industry supplier and category enabler rather than direct competitor to Breakthru's clinical operations, but a key dependency for any TMS-focused practice.

TypeOthers
Description

Manufacturer of Deep TMS systems used by interventional psychiatry clinics across the US. Industry supplier and category enabler rather than direct competitor, but the company's commercial success reflects and supports demand for TMS-based treatment models similar to Breakthru's.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Breakthru Psychiatric Solutions

Interventional Psychiatry Servicesbreakthrupsych.com

Breakthru Psychiatric Solutions is a private interventional psychiatry practice in Georgia providing TMS, Spravato, IV Ketamine, Prism for PTSD, and VNS treatments to patients with treatment-resistant depression, anxiety, PTSD, and OCD.

What Breakthru Psychiatric Solutions does

Breakthru Psychiatric Solutions is a private interventional psychiatry practice founded in 2020 during the COVID pandemic by psychiatrist Dr. Karen Giles, MD and business leader Jim Benjamin, operating under the legal entity Slick Innovations, LLC. The practice operates clinics in Sandy Springs and Alpharetta, Georgia, with a third location in Tucker, GA scheduled to open in July 2026. It serves patients with treatment-resistant mental health conditions — primarily major depressive disorder, anxiety disorders, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD) — who have not responded adequately to traditional antidepressant medications and psychotherapy. Patient volume is generated through a direct-to-consumer model supplemented by healthcare provider referrals, with no enterprise or institutional customers.

The practice's treatment portfolio centers on interventional psychiatric modalities delivered under physician supervision. Core offerings include Transcranial Magnetic Stimulation (TMS) in multiple protocol variants — a standard 9-week protocol, Accelerated TMS (40 iTBS sessions over two weeks), the proprietary ONE-D TMS (20 sessions in a single day combined with Vyvanse and D-cycloserine), AMPLIFI TMS for OCD (targeting DMPFC and rOFC), and MagVenture adolescent TMS for patients ages 15-21. Additional modalities include Spravato (esketamine nasal spray, FDA-approved for treatment-resistant depression), IV Ketamine infusions, Prism for PTSD (an FDA-cleared EEG-based neurofeedback device sourced via a partnership with GrayMatters Health), and Vagus Nerve Stimulation. Breakthru positions itself as the first provider in Georgia to offer ONE-D TMS, and reports clinical outcome figures across modalities, including 93.9% depression improvement with TMS, 95.8% with IV Ketamine, 89.7% with Spravato, and 67% clinically significant symptom improvement with Prism.

Revenue is generated through a dual insurance/self-pay billing model. Traditional TMS, Spravato, and VNS are billed through insurance (Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care) with prior authorization, while IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are self-pay only. The practice is bootstrapped with no disclosed external funding rounds, operates with a 1–10 employee footprint including a five-person physician team, and does not publicly disclose revenue.

Breakthru Psychiatric Solutions firmographics

Firmographics
Name
Breakthru Psychiatric Solutions
Legal name
Slick Innovations, LLC
Website
https://breakthrupsych.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Breakthru Psychiatric Solutions is a private interventional psychiatry practice in Georgia providing TMS, Spravato, IV Ketamine, Prism for PTSD, and VNS treatments to patients with treatment-resistant depression, anxiety, PTSD, and OCD.
Ownership category
akta.pro rank

Breakthru Psychiatric Solutions industry classification

Industry
Product category
Interventional Psychiatry Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Other Ambulatory Health Care Services (6219)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFACAL
Behavioral Health for Children & Adolescents (Youth Services)
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

Keywords

  • Interventional psychiatry
  • Transcranial magnetic stimulation
  • Treatment-resistant depression
  • Esketamine nasal spray
  • IV ketamine therapy

Where Breakthru Psychiatric Solutions is headquartered

Location

Headquarters

HQ city
Sandy Springs
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Breakthru Psychiatric Solutions business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Treatment Services: Revenue generated from providing interventional psychiatric treatments including TMS, Spravato, IV Ketamine, Prism, and VNS. Services are billed through insurance for covered treatments or collected as self-pay for non-covered treatments. Insurance accepted includes Aetna, Anthem Blue Cross Blue Shield, Cigna, Humana, and United Health Care.
  2. Insurance Reimbursements: Traditional TMS, Spravato, and VNS Therapy are covered by many insurance plans. These treatments require prior authorization and are billed through the patient's insurance provider.
  3. Self-Pay Services: IV Ketamine, Accelerated TMS, ONE-D TMS, and Prism for PTSD are not covered by insurance and are collected as self-pay from patients.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractTraditional TMS - 9-week protocol covered by insurance
One time/ perpetual licensePay-as-you-goAccelerated TMS - 2-week protocol (self-pay)
One time/ perpetual licensePay-as-you-goONE-D TMS - One-day treatment (self-pay)
SubscriptionMonthlySpravato - FDA-approved nasal spray (insurance covered)
One time/ perpetual licensePay-as-you-goIV Ketamine - Not covered by insurance (self-pay)
One time/ perpetual licensePay-as-you-goPrism for PTSD - Not covered by insurance (self-pay)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Breakthru Psychiatric Solutions product offering

Product offering

Core offering

Breakthru Psychiatric Solutions provides interventional psychiatric treatments for patients with treatment-resistant mental health conditions (depression, anxiety, PTSD, OCD). The practice administers Transcranial Magnetic Stimulation (TMS) with multiple protocols including ONE-D TMS, Accelerated TMS, AMPLIFI TMS for OCD, and TMS for Adolescents; Spravato (esketamine nasal spray); IV Ketamine infusions; Prism for PTSD neurofeedback; and Vagus Nerve Stimulation (VNS) Therapy. Treatments are delivered under psychiatrist supervision at clinic locations in the Atlanta, Georgia metropolitan area.

Product overview

Breakthru Psychiatric Solutions offers interventional psychiatric treatments for treatment-resistant mental health conditions. The core offerings include three main treatment modalities: Transcranial Magnetic Stimulation (TMS) with multiple protocol variants (Standard TMS, Accelerated TMS, ONE-D TMS, AMPLIFI TMS for OCD, and TMS for Adolescents), Spravato (esketamine nasal spray), and IV Ketamine infusions. Additional treatments include Prism for PTSD (neurofeedback therapy) and Vagus Nerve Stimulation (implanted device). These treatments are offered as alternatives or complements to traditional medication management for patients who have not responded to conventional antidepressant therapies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Transcranial Magnetic Stimulation (TMS)

Quantifiable outcome

  • 93.9% depression improvement, 87.9% anxiety improvement, 42.4% remission rates with TMS
  • +4 more outcomes

Companies that use Breakthru Psychiatric Solutions

Customer profile

Segments6 records

Ideal customer profiles6 records

Breakthru Psychiatric Solutions technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Breakthru Psychiatric Solutions partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GrayMatters HealthcoreTechnology or Integration · 30 October 2024GrayMatters Health is the manufacturer of Prism for PTSD, an FDA-cleared neurofeedback treatment. Breakthru offers Prism as one of their treatment options for PTSD patients. The news indicates expansion of Prism access across multiple clinics including Georgia locations. Clinical trial data published in the Journal of Psychiatry Research demonstrated 67% clinically significant symptom improvement rate among patients using the device.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Breakthru Psychiatric Solutions competitors and assessment

Company assessment

Broad incumbents

  • Cerebral: Digital mental health platform offering medication management and therapy for depression and anxiety. Adjacent mental health space but different delivery model (telehealth) and focuses on pharmaceutical rather than interventional approaches, serving some overlapping patient needs.
  • Amen Clinics: Established brain health clinic chain offering SPECT imaging and psychiatric evaluation services. Overlapping patient demographic in treatment-resistant mental health but different clinical approach focused on brain imaging diagnostics rather than interventional procedures.
  • Mindpath Health: Larger psychiatric services platform offering comprehensive mental health care including therapy, medication management, and interventional treatments. Overlapping patient base in treatment-resistant mental health but broader service portfolio and significantly larger operational scale than Breakthru's specialty focus.

Direct peers

  • Greenbrook TMS: Major North American network of TMS treatment centers offering similar outpatient interventional psychiatry services for treatment-resistant depression. Directly comparable specialty clinic model serving similar patient populations with TMS-focused treatment protocols and physician-supervised delivery.

Others

  • Talkspace: Online therapy platform connecting patients with licensed therapists via text, audio, and video messaging. Different delivery model and treatment approach (talk therapy vs. interventional psychiatry), but serves similar mental health patient population through employer benefits and direct-to-consumer channels.
  • Neuronetics: Manufacturer of the NeuroStar TMS system, a widely-used platform in interventional psychiatry clinics including adolescent applications. Industry supplier and category enabler rather than direct competitor to Breakthru's clinical operations, but a key dependency for any TMS-focused practice.
  • BrainsWay: Manufacturer of Deep TMS systems used by interventional psychiatry clinics across the US. Industry supplier and category enabler rather than direct competitor, but the company's commercial success reflects and supports demand for TMS-based treatment models similar to Breakthru's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Breakthru Psychiatric Solutions social profiles

Digital presence

Breakthru Psychiatric Solutions financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Breakthru Psychiatric Solutions leadership team

Management profile

Number of profiles

Profiles5 records

Breakthru Psychiatric Solutions funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Breakthru Psychiatric Solutions M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Breakthru Psychiatric Solutions

What does Breakthru Psychiatric Solutions do?

Breakthru Psychiatric Solutions provides interventional psychiatric treatments for patients with treatment-resistant mental health conditions (depression, anxiety, PTSD, OCD). The practice administers Transcranial Magnetic Stimulation (TMS) with multiple protocols including ONE-D TMS, Accelerated TMS, AMPLIFI TMS for OCD, and TMS for Adolescents; Spravato (esketamine nasal spray); IV Ketamine infusions; Prism for PTSD neurofeedback; and Vagus Nerve Stimulation (VNS) Therapy. Treatments are delivered under psychiatrist supervision at clinic locations in the Atlanta, Georgia metropolitan area.

Is Breakthru Psychiatric Solutions a public or private company?

Breakthru Psychiatric Solutions is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Breakthru Psychiatric Solutions founded?

Breakthru Psychiatric Solutions was founded in 2020. It employs 1 to 10 people.

Where is Breakthru Psychiatric Solutions based?

Breakthru Psychiatric Solutions is headquartered in Sandy Springs, United States, in the North America region.

How does Breakthru Psychiatric Solutions make money?

Three revenue lines are on record. Medical Treatment Services are the primary driver. The others are insurance Reimbursements and self-Pay Services.

Who are Breakthru Psychiatric Solutions's main competitors?

Broad incumbents on record are Cerebral, Amen Clinics and Mindpath Health. Greenbrook TMS is listed as a direct peer. Others are Talkspace, Neuronetics and BrainsWay.

Does Breakthru Psychiatric Solutions have an API?

No public API is recorded for Breakthru Psychiatric Solutions.

What industry is Breakthru Psychiatric Solutions in?

Breakthru Psychiatric Solutions's product category is Interventional Psychiatry Services. Its primary akta.pro industry code is HLAFACAL, Behavioral Health for Children & Adolescents (Youth Services). Its NAICS code is 621420 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales